1. Introduction {#sec1}
===============

Cardiovascular diseases (CVD) represent the leading causes of death \[[@B1]--[@B3]\]. Nitric oxide (NO) has important role in maintaining cardiovascular homeostasis, such that reduced NO bioavailability precedes atherosclerosis and CVD \[[@B4], [@B5]\]. Endothelial function, as measured by NO dependent flow-mediated dilation (FMD), is a predictor of cardiovascular events \[[@B6], [@B7]\]. Conditions such as insulin resistance, diabetes, and diet affect FMD \[[@B8]\]. Inflammation as well as low NO plays key roles in the activation and progression of atherosclerosis \[[@B9], [@B10]\].

Epidemiologic studies suggest that the Mediterranean diet, which is rich in antioxidants found in fresh fruit and vegetables, is associated with a reduced risk of chronic diseases such as cancer and coronary artery disease \[[@B11]--[@B15]\]. Furthermore, epidemiologic studies consistently report protective effects of polyphenol-rich foods (fruit, tea, wine, cocoa, chocolate, and especially citrus fruit) on some intermediate risk factors for CVD such as LDL cholesterol, blood pressure (BP), and endothelial function \[[@B16]--[@B18]\].

The reduction of oxidative and inflammatory stress by orange juice (OJ) is partially attributed to two flavonoids, hesperidin and naringenin, through decreasing atherogenic LDL cholesterol in hypercholesterolemic (HCH) and increasing HDL ability to take up free cholesterol in HCH and normolipidemic (NC) which may be beneficial for cholesterol esterification and reverse cholesterol transport; in addition, caloric intake in the form of OJ or fructose may not induce either oxidative or inflammatory stress, possibly due to its flavonoids content, and might represent a potentially safe energy source \[[@B19], [@B20]\]. The high global consumption of OJ has resulted in the increased availability of frozen concentrated orange juice to the extent that the market share of this product exceeds that of the fresh fruit. Compared to fresh orange juice, concentrated (commercial) OJ has a greater flavonoid content of polymethoxylated flavones (such as hesperidin) and pectin and essential oils (from the peel) due to the manufacturing process which uses the entire fruit to produce juice \[[@B21]\]. In fact, OJ may decrease diastolic blood pressure (DBP) when regularly consumed and postprandially increases endothelium-dependent microvascular reactivity as well as the possibility that hesperidin could be causally linked to the beneficial effect of OJ \[[@B22]\].

We hypothesized that the intake of commercial (COJ) and fresh (FOJ) orange juice reduces markers of inflammatory stress and so produces short-term favorable effects on endothelial function of healthy volunteers as measured flow-mediated dilation (FMD), serum concentrations of lipids, apolipoproteins A and B (apo A-1 and apo B), and inflammatory markers such as vascular endothelial adhesion molecule 1 (VCAM-1), E-selectin, high-sensitivity C-reactive protein (hs-CRP), and interleukin-6 (IL-6).

2. Methods {#sec2}
==========

Twenty-two healthy volunteers (7 men and 15 women) aged 18--59 years, with no evidence of chronic, metabolic, or endocrine diseases, were invited to participate in a single-blind randomized crossover controlled clinical trial at the Isfahan Cardiovascular Research Center in Isfahan, Iran, in 2012. After explaining the study design, 22 volunteers agreed to participate in the trial. Exclusion criteria used were the use of medications, antioxidant or vitamin supplements, intense physical activity (more than 5 hours per week), smoking, and vegetarian or other restrictive dietary requirements. The Ethics Committee of Isfahan University of Medical Sciences approved the study protocol and completed consent letters were obtained from all participants. Commercial orange juice concentrate and freshly squeezed orange juice were used to prepare COJ and FOJ daily. The participants consumed orange juice in the presence of study investigators, even on holidays and weekends. Participants were required to submit a food diary for the study period.

Participants were randomly assigned into two equal groups each consisting of 11 volunteers. The volunteers in the first group consumed COJ for the first 4 weeks followed by a 2-week washout period; they then consumed FOJ (CFOJ group). The second group consumed FOJ for the first 4 weeks followed by a 2-week washout period; they consumed COJ (FCOJ group). Throughout the two 4-week periods of FOJ or COJ consumption, subjects consumed 500 mL, twice a day with breakfast and dinner \[[@B23], [@B24]\]. We purchased COJ (brand name: Takdaneh Company) and ensured that all COJ was of similar composition. Fresh oranges (*Citrus sinensis* Swing brand) were used to extract juice.

One of the participants in CFOJ group was excluded from the study due to the diagnosis of an underlying disease and this subject was omitted from all data analysis ([Figure 1](#fig1){ref-type="fig"}).

There were four visits for each subject: the day before each experiment (visits 1 and 3) and the day after each experiment (visits 2 and 4) where body mass index (BMI) and FMD measurements were made. Body height was measured to the nearest 0.1 cm with the participants barefooted. Body weight was measured to the nearest 0.05 kg with calibrated digital scales (AMZ 14; Mercury, Tokyo, Japan) with the participants wearing light clothing and no footwear. The BMI index was calculated by dividing the weight (kg) by height (m) squared \[[@B25]\].

Measurements of FMD were made in the fasting state and before withdrawal of blood samples. Twelve-hour fasted blood samples (5 mL) were collected from the left antecubital vein between 8:00 and 9:30 a.m. Blood was collected in vacutainer tubes without anticoagulant, under quality control and safety procedures. Serum was separated from blood 2-3 hrs after sampling by centrifugation at 3500--4000 rpm for 10 min. Collected sera were stored at −80°C until analysis. Serum lipid profile (comprising total cholesterol, triglycerides, and low- (LDL-C) and high-density lipoprotein cholesterol (HDL-C)) along with high-sensitivity C-reactive protein (hs-CRP) and fasting blood sugar (FBS) was determined using automated enzymatic assays (Pars Azmoon, Tehran, Iran) on a Hitachi 902 autoanalyzer. Serum concentrations of adhesion molecules including vascular endothelial adhesion molecule 1 (VCAM-1) and E-selectin together with interleukin-6 (IL-6) were measured by enzyme-linked immunosorbent assay (ELISA) kits (Boster Biological Technology, Wuhun, China). Apo B and Apo A-1 concentrations were quantified using a modified commercially available immunoturbidimetric assay according to the kit instructions (Pars Azmoon, Tehran, Iran). Endothelial function as measured by flow-mediated dilation (FMD) in the right brachial artery was determined before and after each ultrasonography and was calculated as the percentage change from baseline diameter \[[@B26]\].

3. Statistical Analysis {#sec3}
=======================

Statistical analysis was conducted using Proc Mixed from SAS statistical software (version 9.2; SAS Institute Inc., Carry, NC). Measurements at the end of each treatment were considered as response variables in a linear mixed model where baseline measurements were covariates. Using this model, we considered the treatment period and their interactions as fixed effects while subjects assigned as random effects. A significant main effect of treatment was indicated when the *P* value of the *F* test for the main effect was lower than 0.05.

Carryover effects was considered within mixed models and Proc Mixed as well for measurements with missing cases. Carryover effects occurred only for FBS and Apo A-1 and treatment effects were estimated by adjusting for the carryover effect.

We compared the clinical characteristics of the two treatment groups (COJ first and FOJ first) using a paired *t*-test for continuous variables. Each treatment effect (COJ effects on base measurement and FOJ effect on baseline measurements) was tested using a paired *t*-test for continuous variables (SPSS, version 19). Data are presented as Mean ± Standard Deviation.

4. Results {#sec4}
==========

The baseline characteristics of participants at day 0 are shown in [Table 1](#tab1){ref-type="table"}. These characteristics, including age, weight, height, waist, BMI, FMD, TC, TG, LDL, HDL, FBS, apoA, apoB, VCAM, hsCRP, IL-6, and E-selectin, were compared between the CFOJ and FCOJ groups. There were no statistically significant differences between the characteristics of two groups at baseline (*P* ^\$^ \> 0.05).

The clinical characteristics of the 21 subjects that completed the study are displayed in [Table 2](#tab2){ref-type="table"}. Consumption of both juices significantly decreased VCAM (*P* ^\$^ \< 0.001), hs-CRP (*P* ^\$^ \< 0.001), and E-selectin (*P* ^\$^ \< 0.001) but significantly increased apoA-1 (in COJ (*P* ^\$^ = 0.019) and FOJ (*P* ^\$^ = 0.003)). A significant decline in LDL occurred in the FOJ group (104.50 ± 27.26 to 99.18 ± 33.46 mg/dL, *P* ^\$^ = 0.049).

There were no statistically significant differences between the characteristics of two groups (*P* ^@^ \> 0.05), with the exception of apo A-1 levels that were significantly increased with both forms of OJ (for FOJ 117.05 ± 22.49 to 132.23 ± 13.09 mg/dL, *P* ^\$^ = 0.003, and for COJ 116.95 ± 18.18 to 126.87 ± 23.01 mg/dL, *P* ^\$^ = 0.019 (*P* ^@^ \< 0.001)).

The percentage variation for each biochemical factor in each OJ group is shown in [Table 3](#tab3){ref-type="table"}. The largest variations occurred with hs-CRP, VCAM in both juice groups.

5. Discussion {#sec5}
=============

We used a single blind crossover randomized clinical trial to study the effects of COJ and FOJ on endothelial function by measuring FMD and inflammatory markers. During the study period, there were no underlying diseases or changes in lifestyle, including body weight, which may have influenced the observed results. Our study shows that OJ affects the physiologic characteristics of healthy people but that there were differences when consuming COJ and FOJ. Diet supplementation with both juices significantly decreased VCAM, hs-CRP, and E-selectin and significantly increased apo A-1. There was a significant decline in LDL in the FOJ group, while consuming FOJ significantly increased apo A-1 levels.

Our results did not reveal changes in FMD. The effects of OJ consumption on FMD have been studied to a limited extent in previous studies. Morand and colleagues reported that daily consumption of 500 mL blond orange juice for 4 weeks significantly improved endothelial function as assessed by cutaneous acetylcholine microvascular reactivity using Doppler laser flow. This effect was observed in the postprandial phase but not under fasting conditions \[[@B22]\]. It is unclear whether anthocyanins have reduced bioavailability due to poor absorption \[[@B27]\] or whether absorption is underestimated because of difficulties in the identification and measurement of all anthocyanin metabolites \[[@B28]\]. Another study tested the effects of cranberry juice (which contains a significant amount of anthocyanins) in subjects with coronary artery disease \[[@B24]\]. Although there was a reduction in the carotid femoral pulse wave velocity (a measure of arterial stiffness), brachial artery FMD did not change.

We also provide evidence that OJ had significant anti-inflammatory effects that resulted in a reduction of hs-CRP concentrations, which is a sensitive marker of inflammatory activation of the vessel wall and a frequently used biomarker of CVD \[[@B30]\]. The reduction of hs-CRP concentrations seemed to be of particular interest because it has been reported that hs-CRP concentrations of 2 mg/L are associated with a 30% reduction in risk of cardiovascular events \[[@B31]\]. The concentrations of inflammatory cytokines measured in this study (IL-6 and TNF-*α*) were also reduced after OJ consumption. Therefore, the observed reduction of hs-CRP, IL-6, E-selectin, and VCAM concentrations may have dampened inflammatory signaling with potentially beneficial effects on atherosclerotic progression \[[@B32]\]. These results are in agreement with in vitro studies that showed an anti-inflammatory action of oranges (mediated by a reduced expression of intracellular adhesion molecule 1, monocyte chemoattractant protein-1, and IL-8) in normal human keratinocytes stimulated with c-interferon and histamine \[[@B33]\].

The synthesis of CRP and other acute-phase proteins by hepatocytes is stimulated by proinflammatory cytokines such as IL-6, IL-1, and TNF-*α*, the expressions of which are regulated by the activation of the proinflammatory transcription factor nuclear transcription factor *κ*B (NF-*κΒ*) \[[@B34]\] that is mediated by oxidative stress. OJ contains antioxidants such as anthocyanins that act as ROS scavengers, an effect that in turn can potentially interfere with transcription factors such as NF-*κΒ*. Other potential mechanisms include the modulation of antioxidant gene transcription via the nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) signaling pathway \[[@B35]\]. Studies investigating the role of anthocyanins in the activation of the Nrf2 pathway are sparse and essentially consist of in vitro experiments on the mechanisms that prevent hepatotoxicity. For example, Hwang et al. \[[@B36]\] reported that anthocyanins induced protective and anti-inflammatory effects on rat hepatocytes and inhibited the NF-*κΒ* and activated Nrf2 pathways; it cannot be excluded that both pathways are also involved in vivo, but this hypothesis remains to be investigated.

Levels of oxidative stress biomarkers such as 8-iso-prostaglandin are decreased after consumption of OJ \[[@B37]\] or other polyphenol-rich beverages \[[@B38]\]. Free radicals and reactive oxygen and nitrogen species react with proteins to lead to the conversion of amino acid residues into carbonyl groups. Therefore, protein carbonyl group (PC) concentrations are considered biomarkers of oxidative stress \[[@B39]\], suggesting that CVD patients should have higher serum PC concentrations. Consumption of OJ produced nonsignificant trends in reducing PC concentrations. It is possible that our study was underpowered for this variable, and a larger study may confirm this trend. It remains to be seen if higher OJ doses or longer periods of OJ intake might induce significant changes in PC concentrations.

6. Limitations {#sec6}
==============

Important intrinsic limitations include the different taste characteristics of the two forms of OJ, making it difficult to design an improved double-blind study. It is unlikely though that prior knowledge of the kind of beverage ingested by the study participants could easily influence FMD or concentrations of inflammatory molecules. Longer treatment and washout periods were avoided to reduce subject burden and limit occurrence of other interacting factors such as infections, spontaneous fluctuations in diet, and physical activity. A carryover effect could not be formally excluded because of the short washout period and the lack of sampling at the start of the second period. The shapes of individual FMD trajectories argued against a significant carryover effect of OJ.

Both FOJ and COJ have relatively high levels of sugar, which can induce at least a mild form of insulin resistance and so alter Apo B and LDL levels. However, our studies were of an acute nature with little evidence of insulin resistance under these conditions as indicated by unchanged BMI and FBS values.

7. Conclusions {#sec7}
==============

To the best of our knowledge, this is the first study to compare the effects of different types of OJ on inflammatory markers using a randomized, crossover, single-blind design. We observed favorable changes in some of inflammatory markers after the consumption of OJ in participants. Both COJ and FOJ positively affected physiological characteristics of healthy volunteers. Although these results may encourage the consumption of oranges, intervention studies are needed to test the effects of these types of OJ on metabolic and cardiovascular endpoints after prolonged consumption.
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###### 

Main characteristics (Mean ± Standard Deviation) of participants at the baseline (day 0).

  Characteristic       Group             *P*-value^\$^     
  -------------------- ----------------- ----------------- -------
  Age (year)           34 ± 11           35 ± 12           0.769
  Weight (kg)          62.70 ± 10.53     70.09 ± 9.80      0.112
  Height (cm)          161.18 ± 10.07    169.27 ± 9.83     0.071
  Waist (cm)           87.70 ± 9.51      89.64 ± 9.96      0.655
  BMI (kg/m^2^)        24.40 ± 5.48      24.65 ± 4.29      0.905
  FMD (%)              3.90 ± 1.10       3.27 ± 0.78       0.146
  TC (mg/dL)           163.20 ± 36.75    179.09 ± 50.89    0.426
  TG (mg/dL)           86.80 ± 35.28     159.09 ± 150.53   0.156
  LDL (mg/dL)          100.10 ± 25.85    104.27 ± 33.71    0.756
  HDL (mg/dL)          52.20 ± 7.87      44.55 ± 9.28      0.057
  FBS (mg/dL)          84.27 ± 8.08      86.36 ± 7.72      0.542
  Apo A-1 (mg/dL)      121.09 ± 20.69    122.91 ± 9.50     0.794
  Apo B (mg/dL)        68.76 ± 16.94     73.73 ± 20.06     0.538
  VCAM (ng/mL)         791.27 ± 281.37   647.91 ± 170.73   0.164
  hsCRP (mg/dL)        1.05 ± 0.89       0.95 ± 0.67       0.770
  IL6 (ng/mL)          6.83 ± 5.26       6.29 ± 4.77       0.808
  E-selectin (ng/mL)   22.43 ± 9.77      27.84 ± 8.73      0.196

COJ: Commercial Orange Juice; FOJ: Fresh Orange Juice; Data expressed as ^\$^ *P-*value for unpaired *t*-test; BMI: Body Mass Index; TC: Total cholesterol; TG: Triglyceride; LDL: Low-density lipoprotein; HDL: High-density lipoprotein; FBS: Fasting blood sugar.

###### 

The effect of fresh and commercial orange juices on characteristics (PROC MIXED) of participants.

  Characteristic       Before FOJ        After FOJ         *P*-value^\$^   Before COJ        After COJ         *P*-value^\$^   *P*-value^@^
  -------------------- ----------------- ----------------- --------------- ----------------- ----------------- --------------- --------------
  Weight (kg)          67.64 ± 11.30     68.27 ± 11.22     0.066           66.38 ± 10.65     66.62 ± 10.32     0.309           0.999
  Waist (cm)           88.36 ± 11.40     88.86 ± 11.12     0.352           88.95 ± 9.65      87.67 ± 9.91      0.053           0.282
  BMI (kg/m^2^)        25.03 ± 5.18      25.27 ± 5.21      0.066           24.46 ± 4.27      24.55 ± 4.68      0.315           0.946
  FMD (%)              3.31 ± 0.08       3.31 ± 0.16       1.00            3.57 ± 0.97       3.57 ± 0.97       1.00            0.887
  TC (mg/dL)           181.32 ± 38.72    174.64 ± 42.18    0.091           170.19 ± 45.83    172.67 ± 41.04    0.698           0.066
  TG (mg/dL)           126.14 ± 112.91   105.68 ± 73.11    0.153           112.81 ± 114.63   107.48 ± 91.04    0.514           0.201
  LDL (mg/dL)          104.50 ± 27.26    99.18 ± 33.46     **0.049**       102.14 ± 33.12    97.71 ± 32.58     0.209           0.307
  HDL (mg/dL)          49.64 ± 11.46     48.64 ± 16.22     0.751           48.76 ± 9.71      46.48 ± 11.61     0.394           0.901
  FBS (mg/dL)          87.86 ± 7.05      91.95 ± 9.72      0.071           88.59 ± 18.28     88.38 ± 11.36     0.888           0.293
  Apo A-1 (mg/dL)      117.05 ± 22.49    132.23 ± 13.09    **0.003**       116.95 ± 18.18    126.87 ± 23.01    0.019           **\<0.001**
  Apo B (mg/dL)        73.86 ± 21.02     69.50 ± 18.88     0.213           70.34 ± 17.11     67.67 ± 19.45     0.377           0.977
  VCAM (ng/mL)         689.05 ± 254.52   533.82 ± 265.88   **\<0.001**     693.82 ± 241.52   532.90 ± 222.47   **\<0.001**     0.687
  hsCRP (ng/ml)        1.06 ± 0.93       0.66 ± 0.63       **\<0.001**     0.89 ± 0.72       0.56 ± 0.38       **0.011**       0.072
  IL 6 (ng/mL)         6.68 ± 6.36       6.59 ± 4.99       0.954           6.40 ± 4.41       7.93 ± 8.03       0.311           0.452
  E-selectin (ng/mL)   24.87 ± 9.20      17.79 ± 6.34      **\<0.00**      24.70 ± 10.17     18.60 ± 7.45      **\<0.001**     0.186

^\$^ *P*-value computed for pair sample *t*-test. ^@^ *P*-value computed from PROC MIXED SAS software.

COJ: Commercial Orange Juice; FOJ: Fresh Orange Juice; FMD: Flow Mediated Dilation; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; TC: Total Cholesterol; TG: Triglyceride; LDL: Low Density Lipoprotein; HDL: High Density Lipoprotein; FBS: Fasting Blood Sugar; Bold *P*-values are significant (*P* \< 0.05).

###### 

Variation percentage of characteristics after intervention compared to baseline in two study groups.

  Characteristic       COJ Users (*N* = 22)   FOJ Users (*N* = 22)
  -------------------- ---------------------- ----------------------
  FMD                  0                      0
  TC (mg/dL)           −1.45                  −3.69
  TG (mg/dL)           −4.73                  −16.22
  LDL (mg/dL)          −4.34                  −5.09
  HDL (mg/dL)          4.91                   2.05
  FBS (mg/dL)          0.32                   4.66
  Apo A-1 (mg/dl)      9.37                   12.97
  Apo B (mg/dl)        −2.90                  −5.91
  VCAM (ng/mL)         −20.50                 −22.53
  hsCRP (ng/mL)        −35.00                 −37.07
  IL6 (ng/mL)          2.38                   −1.41
  E-selectin (ng/mL)   −24.61                 −28.62

+: Increase; −: Decrease; COJ: Commercial Orange Juice; FOJ: Fresh Orange Juice.
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